Clinic Pathological Features Breast Cancer Patients  (%n)
Age  
<50 years 17(56.7)
≥50 years 13(43.3)
Stage  
I 4(13.3)
II 16(53.3)
III 10(33.3)
Estrogen Receptor (ER)  
positive 19(63)
negative 11(37)
Progesterone Receptor (PR)  
positive 18(60)
negative 12(40)
Human Epidermal Growth Factor Receptor-2 (HER2)  
positive
negative
15(50)
15(50)
Table 1: Data of clinic pathological features of 30 breast cancer patients.